Figure 1.
Figure 1. B-cell proliferation in response to anti-RP105 or LPS stimulation. Spleen B cells (1 × 105/well) from wild-type and MyD88–/– mice (A) and wild-type and CD19–/– mice (B-C) were cultured with the indicated concentrations of anti-RP105 Abs (A-B) or LPS (C). Proliferation was assessed by the incorporation of labeled thymidine (1 μCi/well [0.037 MBq/well]) added during the last 16 hours of 72-hour cultures. Values represent the mean counts per minute (cpm; ± SEM) obtained from triplicate cultures. Mean values significantly different from wild-type proliferation levels are indicated, **P < .01. Results represent those obtained in 3 independent experiments.

B-cell proliferation in response to anti-RP105 or LPS stimulation. Spleen B cells (1 × 105/well) from wild-type and MyD88/ mice (A) and wild-type and CD19/ mice (B-C) were cultured with the indicated concentrations of anti-RP105 Abs (A-B) or LPS (C). Proliferation was assessed by the incorporation of labeled thymidine (1 μCi/well [0.037 MBq/well]) added during the last 16 hours of 72-hour cultures. Values represent the mean counts per minute (cpm; ± SEM) obtained from triplicate cultures. Mean values significantly different from wild-type proliferation levels are indicated, **P < .01. Results represent those obtained in 3 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal